封面
市場調查報告書
商品編碼
1770898

生物製程容器市場-全球產業規模、佔有率、趨勢、機會和預測,按容器類型、應用、最終用戶、地區和競爭情況細分,2020-2030 年

Bioprocess Containers Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type of Containers, By Application, By End Users, By Region and Competition, 2020-2030F

出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球生物製程容器市場價值為 46.8 億美元,預計到 2030 年將達到 158.7 億美元,預測期內的複合年成長率為 22.57%。市場快速擴張的主要原因是生物製藥行業擴大採用自動化和機器學習,以及引入支持創新治療產品開發的先進技術。生物製程容器是藥品生產中傳統不銹鋼系統的經濟高效且可靠的替代品。它們的一次性設計提供了靈活性,降低了污染風險,並最大限度地減少了清潔要求。由於其可擴展性和營運效率,這些容器在生物製造中越來越受歡迎。最近的發展也見證了智慧感測器和基於物聯網的功能的整合,進一步增強了生物加工環境中的製程監控和控制。

市場概覽
預測期 2026-2030
2024年市場規模 46.8億美元
2030年市場規模 158.7億美元
2025-2030 年複合年成長率 22.57%
成長最快的領域 3D生物製程容器
最大的市場 北美洲

關鍵市場促進因素

生物製藥研發和個人化醫療的擴展

主要市場挑戰

環境問題和廢棄物管理

主要市場趨勢

智慧科技與物聯網的融合

目錄

第 1 章:產品概述

第2章:研究方法

第3章:執行摘要

第4章:顧客之聲

第5章:全球生物程序容器市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依容器類型(2D 生物製程容器、3D 生物製程容器、其他容器及配件)
    • 按應用(上游製程、下游製程、製程開發)
    • 按最終用戶(生物製藥公司、生命科學研發公司、其他)
    • 按地區(北美、歐洲、亞太、南美、中東和非洲)
    • 按公司分類(2024)
  • 市場地圖
  • 依貨櫃類型
  • 按應用
  • 按最終用戶
  • 按地區

第6章:北美生物製程容器市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美:國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章:歐洲生物程序容器市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲:國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第8章:亞太生物製程容器市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章:南美洲生物程序容器市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章:中東與非洲生物製程容器市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA:國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章:市場動態

  • 驅動程式
  • 挑戰

第 12 章:市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章:全球生物製程容器市場:SWOT 分析

第 14 章:波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 15 章:競爭格局

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Saint-Gobain Group
  • Lonza Group AG
  • Avantor Funding Inc.
  • Merck KGaA
  • Sartorius AG
  • CellBios Healthcare and Lifesciences Pvt Ltd.
  • Cole-Parmer Instrument Co.
  • Biomass Ventures Pte Ltd.

第 16 章:策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 15113

The Global Bioprocess Containers Market was valued at USD 4.68 billion in 2024 and is projected to reach USD 15.87 billion by 2030, growing at a CAGR of 22.57% during the forecast period. The market's rapid expansion is primarily driven by the increasing adoption of automation and machine learning within the biopharmaceutical sector, alongside the introduction of advanced technologies supporting the development of innovative therapeutic products. Bioprocess containers serve as a cost-efficient and reliable alternative to traditional stainless-steel systems in drug manufacturing. Their single-use design offers flexibility, reduces contamination risk, and minimizes cleaning requirements. These containers are increasingly favored in biomanufacturing due to their scalability and operational efficiency. Recent developments have also seen the integration of smart sensors and IoT-based functionalities, further enhancing process monitoring and control within bioprocessing environments.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 4.68 Billion
Market Size 2030USD 15.87 Billion
CAGR 2025-203022.57%
Fastest Growing Segment3D Bioprocess Containers
Largest MarketNorth America

Key Market Drivers

Expansion of Biopharmaceutical R&D and Personalized Medicine

The growing investment in biopharmaceutical research and personalized medicine is a major driver fueling demand for bioprocess containers. These containers, particularly single-use systems, offer key advantages such as reduced contamination risk, scalability, and operational flexibility-features essential for the evolving needs of biopharmaceutical production.

Significant funding initiatives are supporting this trend. In 2024, the U.S. National Institutes of Health (NIH) allocated over $47 billion to medical research, focusing on gene therapies and personalized treatments. Likewise, the European Union's Horizon Europe program earmarked €95.5 billion for innovation and health research between 2021 and 2027.

These investments are catalyzing the development of complex biologics, including monoclonal antibodies, cell therapies, and vaccines. Bioprocess containers play a vital role in this space, offering sterile, disposable solutions that help accelerate production timelines and reduce cross-contamination, thus supporting the efficient delivery of personalized medical solutions.

Key Market Challenges

Environmental Concerns and Waste Management

Despite operational advantages, the single-use nature of bioprocess containers presents a significant environmental challenge due to the generation of plastic-based biomedical waste. The disposal of these materials raises sustainability concerns across the biopharmaceutical industry.

Global regulatory bodies are placing increased emphasis on sustainable manufacturing. For example, the European Union has enacted directives to reduce plastic waste and promote recyclable or biodegradable alternatives. In the United States, the Environmental Protection Agency (EPA) is driving initiatives to manage plastic waste and encourage eco-friendly practices.

However, recycling bioprocess containers remains complex due to contamination risks and material limitations. The lack of standardized disposal protocols and viable recycling infrastructure makes it difficult for manufacturers to meet environmental compliance goals. As a result, the market faces mounting pressure to develop innovative materials and waste mitigation strategies that align with growing sustainability expectations.

Key Market Trends

Integration of Smart Technologies and IoT

The incorporation of smart technologies and IoT into bioprocess containers is transforming modern biomanufacturing. Smart containers equipped with real-time sensors and digital connectivity are enabling manufacturers to monitor critical process parameters such as temperature, pH, and pressure with high precision.

Governmental support for digital innovation in manufacturing is reinforcing this trend. The U.S. Department of Commerce's NIST and the European Commission's Industry 5.0 initiative both promote the adoption of intelligent systems to enhance industrial efficiency and adaptability.

This movement aligns with the broader evolution toward Industry 4.0, where automation, data analytics, and machine-to-machine communication are key drivers of operational excellence. Smart bioprocess containers enable predictive maintenance, improve traceability, reduce downtime, and support regulatory compliance-collectively enhancing product quality and manufacturing efficiency.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • Danaher Corporation
  • Saint-Gobain Group
  • Lonza Group AG
  • Avantor Funding Inc.
  • Merck KGaA
  • Sartorius AG
  • CellBios Healthcare and Lifesciences Pvt Ltd.
  • Cole-Parmer Instrument Co.
  • Biomass Ventures Pte Ltd.

Report Scope:

In this report, the Global Bioprocess Containers Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Bioprocess Containers Market, By Type of Containers:

  • 2D Bioprocess Containers
  • 3D Bioprocess Containers
  • Other Containers and Accessories

Bioprocess Containers Market, By Application:

  • Upstream Process
  • Downstream Process
  • Process Development

Bioprocess Containers Market, By End Users:

  • Biopharmaceutical Companies
  • Life Science R&D Companies
  • Others

Bioprocess Containers Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Bioprocess Containers Market.

Available Customizations:

Global Bioprocess Containers Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Bioprocess Containers Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
    • 5.2.2. By Application (Upstream Process, Downstream Process, Process Development)
    • 5.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
    • 5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
    • 5.2.5. By Company (2024)
  • 5.3. Market Map
  • 5.3.1 By Type of Containers
  • 5.3.2 By Application
  • 5.3.3 By End Users
  • 5.3.4 By Region

6. North America Bioprocess Containers Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
    • 6.2.2. By Application (Upstream Process, Downstream Process, Process Development)
    • 6.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Bioprocess Containers Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type of Containers
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Bioprocess Containers Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type of Containers
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Bioprocess Containers Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type of Containers
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Bioprocess Containers Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
    • 7.2.2. By Application (Upstream Process, Downstream Process, Process Development)
    • 7.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Bioprocess Containers Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Containers
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. Germany Bioprocess Containers Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Containers
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Bioprocess Containers Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Containers
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Bioprocess Containers Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Type of Containers
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Bioprocess Containers Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Type of Containers
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Bioprocess Containers Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
    • 8.2.2. By Application (Upstream Process, Downstream Process, Process Development)
    • 8.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Bioprocess Containers Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Containers
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Bioprocess Containers Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Containers
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Bioprocess Containers Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Containers
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Bioprocess Containers Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of Containers
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Bioprocess Containers Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of Containers
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Bioprocess Containers Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
    • 9.2.2. By Application (Upstream Process, Downstream Process, Process Development)
    • 9.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Bioprocess Containers Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Containers
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Bioprocess Containers Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Containers
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Bioprocess Containers Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Containers
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Bioprocess Containers Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of Containers (2D Bioprocess Containers, 3D Bioprocess Containers, Other Containers and Accessories)
    • 10.2.2. By Application (Upstream Process, Downstream Process, Process Development)
    • 10.2.3. By End Users (Biopharmaceutical Companies, Life Science R&D Companies, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Bioprocess Containers Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Containers
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Bioprocess Containers Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of Containers
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Bioprocess Containers Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Containers
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Bioprocess Containers Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Thermo Fisher Scientific Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Danaher Corporation
  • 15.3. Saint-Gobain Group
  • 15.4. Lonza Group AG
  • 15.5. Avantor Funding Inc.
  • 15.6. Merck KGaA
  • 15.7. Sartorius AG
  • 15.8. CellBios Healthcare and Lifesciences Pvt Ltd.
  • 15.9. Cole-Parmer Instrument Co.
  • 15.10. Biomass Ventures Pte Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer